Page 30 - Nuclear Detection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under The Market Abuse Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain. Not for publication, distribution or release directly or indirectly, in whole or in part, in or into the United States of America, Canada, Australia, Japan, the Republic of Irelan...

· Gross margin was 54% (H1 2019/20: 58%; FY 2019/20: 47%) · Adjusted EBITDA* was £0.9m loss (H1 2019/20: £0.6m loss) · Loss before tax was £3.4m (H1 2019/20: £2.7m loss) · Cash and cash equivalents at 31 October 2020 were £5.8m (30 April 2020: £9.4m; 31 October 2019: £13.4m) * Adjusted EBITDA is defined as earnings before interest, taxation, depreciation, amortisation, other income and share-based payments. For further details, see the Financial Review below.   Operational Summary ·     R...